Beckman Coulter shoots down biotech's stem cell trade mark

Beckman Coulter shoots down biotech’s stem cell trade mark

Intellectual Property 2025-03-25 11:25 pm By Andy Sidler | Melbourne

Please login to bookmark

US lab products giant Beckman Coulter has successfully opposed an Australian biotech’s bid to trade mark ‘Cytophex’ for its stem cell expansion system, with an IP Australia delegate finding the mark is too similar to Beckman’s ‘CytoFLEX’ mark.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au